Literature DB >> 19762465

The Ig domain protein CD9P-1 down-regulates CD81 ability to support Plasmodium yoelii infection.

Stéphanie Charrin1, Samir Yalaoui, Birke Bartosch, Laurence Cocquerel, Jean-François Franetich, Claude Boucheix, Dominique Mazier, Eric Rubinstein, Olivier Silvie.   

Abstract

Invasion of hepatocytes by Plasmodium sporozoites is a prerequisite for establishment of a malaria natural infection. The molecular mechanisms underlying sporozoite invasion are largely unknown. We have previously reported that CD81 is required on hepatocytes for infection by Plasmodium falciparum and Plasmodium yoelii sporozoites. CD81 belongs to the tetraspanin superfamily of transmembrane proteins. By interacting with each other and with other transmembrane proteins, tetraspanins may play a role in the lateral organization of membrane proteins. In this study, we investigated the role of the two major molecular partners of CD81 in hepatocytic cells, CD9P-1/EWI-F and EWI-2, two transmembrane proteins belonging to a novel subfamily of immunoglobulin proteins. We show that CD9P-1 silencing increases the host cell susceptibility to P. yoelii sporozoite infection, whereas EWI-2 knock-down has no effect. Conversely, overexpression of CD9P-1 but not EWI-2 partially inhibits infection. Using CD81 and CD9P-1 chimeric molecules, we demonstrate the role of transmembrane regions in CD81-CD9P-1 interactions. Importantly, a CD9P-1 chimera that no longer associates with CD81 does not affect infection. Based on these data, we conclude that CD9P-1 acts as a negative regulator of P. yoelii infection by interacting with CD81 and regulating its function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19762465      PMCID: PMC2797227          DOI: 10.1074/jbc.M109.057927

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  GXXXG and AXXXA: common alpha-helical interaction motifs in proteins, particularly in extremophiles.

Authors:  Gary Kleiger; Robert Grothe; Parag Mallick; David Eisenberg
Journal:  Biochemistry       Date:  2002-05-14       Impact factor: 3.162

2.  EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells.

Authors:  Stéphanie Charrin; François Le Naour; Valérie Labas; Martine Billard; Jean-Pierre Le Caer; Jean-François Emile; Marie-Anne Petit; Claude Boucheix; Eric Rubinstein
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

3.  Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity.

Authors:  Olivier Silvie; Eric Rubinstein; Jean-François Franetich; Michel Prenant; Elodie Belnoue; Laurent Rénia; Laurent Hannoun; Wijnand Eling; Shoshana Levy; Claude Boucheix; Dominique Mazier
Journal:  Nat Med       Date:  2002-12-16       Impact factor: 53.440

4.  Analysis of the CD151-alpha3beta1 integrin and CD151-tetraspanin interactions by mutagenesis.

Authors:  F Berditchevski; E Gilbert; M R Griffiths; S Fitter; L Ashman; S J Jenner
Journal:  J Biol Chem       Date:  2001-07-30       Impact factor: 5.157

5.  A transient three-plasmid expression system for the production of high titer retroviral vectors.

Authors:  Y Soneoka; P M Cannon; E E Ramsdale; J C Griffiths; G Romano; S M Kingsman; A J Kingsman
Journal:  Nucleic Acids Res       Date:  1995-02-25       Impact factor: 16.971

6.  FPRP, a major, highly stoichiometric, highly specific CD81- and CD9-associated protein.

Authors:  C S Stipp; D Orlicky; M E Hemler
Journal:  J Biol Chem       Date:  2000-11-21       Impact factor: 5.157

Review 7.  Sneaking in through the back entrance: the biology of malaria liver stages.

Authors:  Ute Frevert
Journal:  Trends Parasitol       Date:  2004-09

8.  Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor.

Authors:  Birke Bartosch; Alessandra Vitelli; Christelle Granier; Caroline Goujon; Jean Dubuisson; Simona Pascale; Elisa Scarselli; Riccardo Cortese; Alfredo Nicosia; François-Loïc Cosset
Journal:  J Biol Chem       Date:  2003-08-11       Impact factor: 5.157

9.  Proteoglycans mediate malaria sporozoite targeting to the liver.

Authors:  Gabriele Pradel; Shivani Garapaty; Ute Frevert
Journal:  Mol Microbiol       Date:  2002-08       Impact factor: 3.501

10.  An extracellular site on tetraspanin CD151 determines alpha 3 and alpha 6 integrin-dependent cellular morphology.

Authors:  Alexander R Kazarov; Xiuwei Yang; Christopher S Stipp; Bantoo Sehgal; Martin E Hemler
Journal:  J Cell Biol       Date:  2002-09-30       Impact factor: 10.539

View more
  11 in total

1.  Interacting regions of CD81 and two of its partners, EWI-2 and EWI-2wint, and their effect on hepatitis C virus infection.

Authors:  Claire Montpellier; Birke Andrea Tews; Julien Poitrimole; Vera Rocha-Perugini; Valentina D'Arienzo; Julie Potel; Xin A Zhang; Eric Rubinstein; Jean Dubuisson; Laurence Cocquerel
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

2.  Proteomics of HCV virions reveals an essential role for the nucleoporin Nup98 in virus morphogenesis.

Authors:  Marion Lussignol; Martina Kopp; Kelly Molloy; Gema Vizcay-Barrena; Roland A Fleck; Marcus Dorner; Kierstin L Bell; Brian T Chait; Charles M Rice; Maria Teresa Catanese
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-16       Impact factor: 11.205

3.  Normal muscle regeneration requires tight control of muscle cell fusion by tetraspanins CD9 and CD81.

Authors:  Stéphanie Charrin; Mathilde Latil; Sabrina Soave; Anna Polesskaya; Fabrice Chrétien; Claude Boucheix; Eric Rubinstein
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 4.  CD81 and hepatitis C virus (HCV) infection.

Authors:  Lucie Fénéant; Shoshana Levy; Laurence Cocquerel
Journal:  Viruses       Date:  2014-02-06       Impact factor: 5.048

5.  The Host Protein Aquaporin-9 is Required for Efficient Plasmodium falciparum Sporozoite Entry into Human Hepatocytes.

Authors:  Nadia Amanzougaghene; Shahin Tajeri; Samir Yalaoui; Audrey Lorthiois; Valérie Soulard; Audrey Gego; Armelle Rametti; Véronica Risco-Castillo; Alicia Moreno; Maurel Tefit; Geert-Jan van Gemert; Robert W Sauerwein; Jean-Christophe Vaillant; Philippe Ravassard; Jean-Louis Pérignon; Patrick Froissard; Dominique Mazier; Jean-François Franetich
Journal:  Front Cell Infect Microbiol       Date:  2021-06-29       Impact factor: 5.293

Review 6.  Regulation of ADAM10 by the TspanC8 Family of Tetraspanins and Their Therapeutic Potential.

Authors:  Neale Harrison; Chek Ziu Koo; Michael G Tomlinson
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

Review 7.  Immune evasion strategies of pre-erythrocytic malaria parasites.

Authors:  Hong Zheng; Zhangping Tan; Wenyue Xu
Journal:  Mediators Inflamm       Date:  2014-05-07       Impact factor: 4.711

8.  Plasmodium P36 determines host cell receptor usage during sporozoite invasion.

Authors:  Giulia Manzoni; Carine Marinach; Selma Topçu; Sylvie Briquet; Morgane Grand; Matthieu Tolle; Marion Gransagne; Julien Lescar; Chiara Andolina; Jean-François Franetich; Mirjam B Zeisel; Thierry Huby; Eric Rubinstein; Georges Snounou; Dominique Mazier; François Nosten; Thomas F Baumert; Olivier Silvie
Journal:  Elife       Date:  2017-05-16       Impact factor: 8.713

9.  EWI-2wint promotes CD81 clustering that abrogates Hepatitis C Virus entry.

Authors:  Julie Potel; Patrice Rassam; Claire Montpellier; Laura Kaestner; Elisabeth Werkmeister; Birke A Tews; Cyril Couturier; Costin-Ioan Popescu; Thomas F Baumert; Eric Rubinstein; Jean Dubuisson; Pierre-Emmanuel Milhiet; Laurence Cocquerel
Journal:  Cell Microbiol       Date:  2013-02-16       Impact factor: 3.715

10.  Implications for tetraspanin-enriched microdomain assembly based on structures of CD9 with EWI-F.

Authors:  Wout Oosterheert; Katerina T Xenaki; Viviana Neviani; Wouter Pos; Sofia Doulkeridou; Jip Manshande; Nicholas M Pearce; Loes Mj Kroon-Batenburg; Martin Lutz; Paul Mp van Bergen En Henegouwen; Piet Gros
Journal:  Life Sci Alliance       Date:  2020-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.